← Leaderboards
Ruben Tommasi
Entasis Therapeutics, Inc.
$5,863,913
Attributed
$5,863,913
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2020–21$5M$3.8M$2.5M$1.3M$0
'20
'21
Funding mix
By agency
NIH$5,863,913 · 1
By mechanism
N01$5,863,913 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Therapeutic Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$311,659,176
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Therapeutic DevelopmentBacterial Antibiotic ResistanceCategoriesChemistryResearch And DevelopmentTherapeutic CandidateAdvanced DevelopmentEmerging Communicable DiseasesNational Institute Of Allergy And Infectious DiseasePathway InteractionsPre-ClinicalPriority PathogenProduct DevelopmentEfficacy EvaluationSafety AssessmentSafety